Terms: = Pancreatic cancer AND CD79A, ENSG00000105369, 973, P11912, MB-1, IGA AND Prognosis
10 results:
1. Polymeric immunoglobulin receptor (pIgR) in cancer.
Chae J; Choi J; Chung J
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17683-17690. PubMed ID: 37897659
[TBL] [Abstract] [Full Text] [Related]
2. The Impact of Sarcopenia Onset Prior to cancer Diagnosis on cancer Survival: A National Population-Based Cohort Study Using Propensity Score Matching.
Su CH; Chen WM; Chen MC; Shia BC; Wu SY
Nutrients; 2023 Mar; 15(5):. PubMed ID: 36904245
[TBL] [Abstract] [Full Text] [Related]
3. A Predictive Model Based on the Gut Microbiota Improves the Diagnostic Effect in Patients With Cholangiocarcinoma.
Zhang T; Zhang S; Jin C; Lin Z; Deng T; Xie X; Deng L; Li X; Ma J; Ding X; Liu Y; Shan Y; Yu Z; Wang Y; Chen G; Li J
Front Cell Infect Microbiol; 2021; 11():751795. PubMed ID: 34888258
[TBL] [Abstract] [Full Text] [Related]
4. HIST3H2A is a potential biomarker for pancreatic cancer: A study based on TCGA data.
Zhao M; Dai R
Medicine (Baltimore); 2021 Nov; 100(46):e27598. PubMed ID: 34797282
[TBL] [Abstract] [Full Text] [Related]
5. Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study.
Kim IH; Choi MH; Lee IS; Hong TH; Lee MA
BMC Cancer; 2021 Jan; 21(1):77. PubMed ID: 33461517
[TBL] [Abstract] [Full Text] [Related]
6. Controversial Role of Adjuvant Therapy in Node-Negative Invasive Intraductal Papillary Mucinous Neoplasm.
Mungo B; Croce C; Oba A; Ahrendt S; Gleisner A; Friedman C; Schulick RD; Del Chiaro M
Ann Surg Oncol; 2021 Mar; 28(3):1533-1542. PubMed ID: 32743713
[TBL] [Abstract] [Full Text] [Related]
7. Tumor Budding in Intrahepatic Cholangiocarcinoma: A Predictor of Postsurgery Outcomes.
Tanaka M; Yamauchi N; Ushiku T; Shibahara J; Hayashi A; Misumi K; Yasunaga Y; Morikawa T; Kokudo T; Arita J; Sakamoto Y; Hasegawa K; Fukayama M
Am J Surg Pathol; 2019 Sep; 43(9):1180-1190. PubMed ID: 31335353
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic values of common clinical parameters in advanced pancreatic ductal adenocarcinoma: a large multicenter cohort study of ten years.
Zhang C; Dong S; Wang L; Yu S; Zheng Y; Geng Y; Shen X; Ying H; Guo Y; Yu J; Deng Q; Meng Z; Li Z; Chen H; Shen Y; Chen Q
Discov Med; 2018 Mar; 25(137):91-98. PubMed ID: 29641971
[TBL] [Abstract] [Full Text] [Related]
9. ALDH1L1 variant rs2276724 and mRNA expression predict post-operative clinical outcomes and are associated with TP53 expression in HBV-related hepatocellular carcinoma.
Zhu G; Liao X; Han C; Liu X; Yu L; Qin W; Lu S; Su H; Chen Z; Liu Z; Liang Y; Huang J; Yu T; Yang C; Huang K; Shang L; Ye X; Li L; Qin X; Xiao K; Peng M; Peng T
Oncol Rep; 2017 Sep; 38(3):1451-1463. PubMed ID: 28714006
[TBL] [Abstract] [Full Text] [Related]
10. Extensive extramedullary disease in myeloma. An uncommon variant with features of poor prognosis and dedifferentiation.
Sanal SM; Yaylaci M; Mangold KA; Pantazis CG
Cancer; 1996 Apr; 77(7):1298-302. PubMed ID: 8608506
[TBL] [Abstract] [Full Text] [Related]
